Famotidine/Lansoprazole Combination Pack from Canada
Combination packs pair famotidine tablets with lansoprazole capsules for dual-action digestive relief in retail sale. Primarily famotidine-driven, classified under HTS 3004.90.92.54 per specific content.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Ratio documentation showing famotidine dominance for specific subheading
• Set packaging treated as single unit for classification